SeekingAlpha · Sep 25, 2026
Plexus: Growth Has Arrived, But The Cash Must Follow
Plexus posts 28% revenue growth, but valuation looks full at 26.4x forward P/E. Click to learn more about PLXS' risks and why free cash flow is key.
NASDAQ · PLXS
Technology · Hardware, Equipment & Parts
$263.09
Up+$1.87 (+0.71%)
Updated Sep 28, 2026, 8:23 PM
SID Score
6.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance · PLXS
1M range · 19 trading sessions · Daily adjusted prices
Prices through Sep 25, 2026
PLXS closed at $263.09 after 19 trading sessions, up 9.86% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $265.86 | $269.79 | $262.71 | $263.09 | 207K |
| Sep 24, 2026 | $260.10 | $266.25 | $258.61 | $261.61 | 197.08K |
| Sep 23, 2026 | $263.26 | $264.565 | $259.15 | $263.90 | 214.06K |
| Sep 22, 2026 | $259.25 | $265.38 | $256.31 | $263.33 | 404.71K |
| Sep 21, 2026 | $251.82 | $252.945 | $247.68 | $252.36 | 237.05K |
| Sep 18, 2026 | $246.77 | $248.60 | $243.36 | $246.73 | 405.03K |
| Sep 17, 2026 | $246.01 | $248.86 | $244.80 | $245.74 | 158.03K |
| Sep 16, 2026 | $242.41 | $245.505 | $238.82 | $242.33 | 223.06K |
| Sep 15, 2026 | $241.73 | $246.41 | $236.58 | $238.53 | 233.61K |
| Sep 14, 2026 | $244.98 | $246.06 | $239.35 | $239.63 | 197.36K |
| Sep 11, 2026 | $250.03 | $256.67 | $250.03 | $255.34 | 146.68K |
| Sep 10, 2026 | $244.71 | $248.35 | $243.82 | $246.94 | 129.41K |
| Sep 9, 2026 | $247.42 | $252.975 | $246.38 | $248.25 | 140.39K |
| Sep 8, 2026 | $246.32 | $251.87 | $246.32 | $249.90 | 173.02K |
| Sep 4, 2026 | $243.37 | $248.07 | $241.855 | $245.98 | 210.15K |
| Sep 3, 2026 | $241.62 | $242.9699 | $236.01 | $242.07 | 214.72K |
| Sep 2, 2026 | $239.29 | $242.32 | $235.33 | $239.29 | 184.51K |
| Sep 1, 2026 | $239.47 | $241.30 | $234.395 | $238.57 | 325.08K |
| Aug 31, 2026 | $240.87 | $243.83 | $236.60 | $239.47 | 206.25K |
The latest Smart Investors Daily articles mentioning PLXS.
PLXS research
Company profile and research snapshot.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | Keybanc | Overweight | — |
| Aug 14, 2026 | Needham | Buy | — |
| Jul 31, 2026 | Sidoti & Co. | Buy | — |
| Jun 22, 2026 | Stifel | Buy | — |
| Jun 1, 2026 | Needham | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 25, 2026
Plexus posts 28% revenue growth, but valuation looks full at 26.4x forward P/E. Click to learn more about PLXS' risks and why free cash flow is key.
Benzinga · Sep 22, 2026
Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.
Benzinga · Sep 22, 2026
Keybanc analyst Steve Barger upgrades Plexus (NASDAQ:PLXS) from Sector Weight to Overweight and announces $300 price target.
Yahoo · Sep 21, 2026
Plexus (PLXS) has quietly drawn attention after recent share price gains over the past month, even as returns over the past three months moved in the opposite direction for holders. That recent upswing sits on top of a strong backdrop for Plexus, with the 1-year total shareholder return at 75.71% and the 3-year total shareholder return at 177.35%. However, the 90-day share price return declined 12.55%, suggesting momentum has cooled after a sharp run. Scan Plexus alongside a curated group of...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PLXS.